Amdocs Stock Beta
| DOX Stock | USD 85.11 0.18 0.21% |
Amdocs fundamentals help investors to digest information that contributes to Amdocs' financial success or failures. It also enables traders to predict the movement of Amdocs Stock. The fundamental analysis module provides a way to measure Amdocs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amdocs stock.
Amdocs | Beta |
Amdocs Company Beta Analysis
Amdocs' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Amdocs Beta | 0.69 |
Most of Amdocs' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Amdocs Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Amdocs is extremely important. It helps to project a fair market value of Amdocs Stock properly, considering its historical fundamentals such as Beta. Since Amdocs' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amdocs' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amdocs' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Amdocs has a Beta of 0.694. This is 34.53% lower than that of the IT Services sector and significantly higher than that of the Information Technology industry. The beta for all United States stocks is notably lower than that of the firm.
Amdocs Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.Amdocs is currently under evaluation in beta category among related companies.
Amdocs ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Amdocs Institutional Holders
Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.| Shares | American Century Companies Inc | 2023-12-31 | 2 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.7 M | Alliancebernstein L.p. | 2023-12-31 | 1.7 M | State Street Corporation | 2023-12-31 | 1.6 M | Vanguard Group Inc | 2023-12-31 | 1.5 M | Brandes Investment Partners & Co | 2023-12-31 | 1.4 M | Norges Bank | 2023-12-31 | 1.4 M | Wellington Management Company Llp | 2023-12-31 | 1.3 M | Principal Financial Group Inc | 2023-12-31 | 1.2 M | Fmr Inc | 2023-12-31 | 17.5 M | Hhg Plc | 2023-12-31 | 6.5 M |
As returns on the market increase, Amdocs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Amdocs is expected to be smaller as well.
Amdocs Fundamentals
| Return On Equity | 0.16 | |||
| Return On Asset | 0.071 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 10.15 B | |||
| Shares Outstanding | 116.5 M | |||
| Shares Owned By Institutions | 97.38 % | |||
| Number Of Shares Shorted | 1.89 M | |||
| Price To Earning | 19.03 X | |||
| Price To Book | 2.81 X | |||
| Price To Sales | 2.02 X | |||
| Revenue | 4.89 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 920.59 M | |||
| Net Income | 542.96 M | |||
| Cash And Equivalents | 817.98 M | |||
| Cash Per Share | 6.74 X | |||
| Total Debt | 807.31 M | |||
| Debt To Equity | 0.23 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 30.55 X | |||
| Cash Flow From Operations | 822.63 M | |||
| Short Ratio | 2.57 X | |||
| Earnings Per Share | 4.68 X | |||
| Price To Earnings To Growth | 1.20 X | |||
| Target Price | 104.9 | |||
| Number Of Employees | 29 K | |||
| Beta | 0.69 | |||
| Market Capitalization | 9.88 B | |||
| Total Asset | 6.43 B | |||
| Retained Earnings | 6.55 B | |||
| Working Capital | 558.25 M | |||
| Current Asset | 2.1 B | |||
| Current Liabilities | 1.37 B | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.73 % | |||
| Net Asset | 6.43 B | |||
| Last Dividend Paid | 1.74 |
About Amdocs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amdocs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Amdocs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.Moving against Amdocs Stock
| 0.71 | EGIO | Edgio Inc Report 17th of July 2024 | PairCorr |
| 0.7 | NN | Nextnav Acquisition Corp Financial Report 8th of May 2024 | PairCorr |
| 0.56 | GB | Global Blue Group | PairCorr |
| 0.56 | VERI | Veritone Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Amdocs Piotroski F Score and Amdocs Altman Z Score analysis. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 1.74 | Earnings Share 4.68 | Revenue Per Share 41.665 | Quarterly Revenue Growth 0.05 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.